Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
303. lappuse
... approximately 200 milliliters . Adjust the pH to 7.2 using hydrochloric acid or sodium hydroxide . The solution must be clear at this stage . If sodium chloride is to be used in preparing the batch add 25 milliliters of 4.2 percent ( w ...
... approximately 200 milliliters . Adjust the pH to 7.2 using hydrochloric acid or sodium hydroxide . The solution must be clear at this stage . If sodium chloride is to be used in preparing the batch add 25 milliliters of 4.2 percent ( w ...
305. lappuse
... approximately 40 , 80 , or 100 units of insulin per milliliter in a quantity containing approximately 5,000 U.S.P. units of insulin . ( 3 ) If the batch is to be protamine zinc insulin suspension , a trial mixture which is intended to ...
... approximately 40 , 80 , or 100 units of insulin per milliliter in a quantity containing approximately 5,000 U.S.P. units of insulin . ( 3 ) If the batch is to be protamine zinc insulin suspension , a trial mixture which is intended to ...
332. lappuse
... approximately equal . In no case , however , shall more than 5,000 imme- diate containers have been packaged during each such interval of sampling , except for a sample collected for steril- ity testing . ( ii ) In the case of drugs in ...
... approximately equal . In no case , however , shall more than 5,000 imme- diate containers have been packaged during each such interval of sampling , except for a sample collected for steril- ity testing . ( ii ) In the case of drugs in ...
354. lappuse
... approximately 25 ° C. and store at 20 ° C. to 30 ° C. The sterility of each lot of tubes of liquid medium may be confirmed by incubating an adequate number of tubes as described in the test procedures in paragraph ( e ) of this section ...
... approximately 25 ° C. and store at 20 ° C. to 30 ° C. The sterility of each lot of tubes of liquid medium may be confirmed by incubating an adequate number of tubes as described in the test procedures in paragraph ( e ) of this section ...
355. lappuse
... approximately 10,000 Levy units of pen- icillinase . ( 13 ) Medium M. To each liter of Me- dium E add 1 milliliter of p - tert- octylphenoxy polyethoxyethanol and approximately 10,000 Levy units of pen- icillinase . ( 14 ) Medium N ...
... approximately 10,000 Levy units of pen- icillinase . ( 13 ) Medium M. To each liter of Me- dium E add 1 milliliter of p - tert- octylphenoxy polyethoxyethanol and approximately 10,000 Levy units of pen- icillinase . ( 14 ) Medium N ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning